National Center for Environmental Health/Agency for Toxic Substances and Disease Registry, 14221 [06-2653]

Download as PDF Federal Register / Vol. 71, No. 54 / Tuesday, March 21, 2006 / Notices Dated: March 14, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 06–2652 Filed 3–20–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention sroberts on PROD1PC70 with NOTICES National Center for Environmental Health/Agency for Toxic Substances and Disease Registry The Board of Scientific Counselors, Centers for Disease Control and Prevention (CDC), National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (NCEH/ ATSDR): Meeting. In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), CDC and NCEH/ ATSDR announce the following committee meeting: Name: Board of Scientific Counselors (BSC), NCEH/ATSDR. Times and Dates: 8 a.m. –4:45 p.m., May 4, 2006. 8 a.m.–12:15 p.m., May 5, 2006. Place: 1825 Century Boulevard, Atlanta, Georgia 30345. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 75 people. Purpose: The Secretary, Department of Health and Human Services (HHS) and by delegation, the Director, CDC, and Administrator, NCEH/ATSDR, are authorized under section 301 (42 U.S.C. 241) and section 311 (42 U.S.C. 243) of the Public Health Service Act, as amended, to: (1) Conduct, encourage, cooperate with, and assist other appropriate public authorities, scientific institutions, and scientists in the conduct of research, investigations, experiments, demonstrations, and studies relating to the causes, diagnosis, treatment, control, and prevention of physical and mental diseases and other impairments; (2) assist states and their political subdivisions in the prevention of infectious diseases and other preventable conditions and in the promotion of health and well being; and (3) train state and local personnel in health work. The BSC, NCEH/ATSDR provides advice and guidance to the Secretary, HHS; the Director, CDC, and Administrator, ATSDR; and the Director, NCEH/ATSDR, regarding program goals, objectives, strategies, and priorities in fulfillment of the agency’s VerDate Aug<31>2005 19:01 Mar 20, 2006 Jkt 208001 mission to protect and promote people’s health. The board provides advice and guidance that will assist NCEH/ATSDR in ensuring scientific quality, timeliness, utility, and dissemination of results. The board also provides guidance to help NCEH/ATSDR work more efficiently and effectively with its various constituents and to fulfill its mission in protecting America’s health. Matters To Be Discussed: Items will include but are not limited to a discussion of Fiscal Years 2006 and 2007 budget implications; an update on the peer review of the Air Pollution and Respiratory Health Branch and the Division of Toxicology and Environmental Medicine; a discussion of the Program Peer Review Subcommittee process; updates on the Community and Tribal Subcommittee, the Health Department Subcommittee and the Delisting Workgroup; a discussion on the implications of the Office of Management and Budget Data Quality Guidelines and proposed bulletin on risk assessments; a discussion on the environmental health aspects of pandemic flu planning, the environmental health implications; discussion on future goals, directions, and new priorities; and an introduction of the Goals’ Managers. Agenda items are tentative and subject to change. FOR FURTHER INFORMATION CONTACT: Sandra Malcom, Committee Management Specialist, NCEH/ATSDR, 1600 Clifton Road, Mail Stop E–28, Atlanta, Georgia 30303; telephone (404) 498–0003, fax (404) 498–0622; E-mail: smalcom@cdc.gov. The deadline for notification of attendance is April 24, 2006. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and NCEH/ATSDR. Dated: March 14, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. 06–2653 Filed 3–20–06; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 14221 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Prospective Grant of Exclusive License: Dengue Virus Vaccine Technology Transfer Office, Centers for Disease Control and Prevention (CDC), Department of Health and Human Services. ACTION: Notice. AGENCY: SUMMARY: This is a notice in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i) that the Centers for Disease Control and Prevention (CDC), Technology Transfer Office, Department of Health and Human Services (DHHS), is contemplating the grant of a worldwide, limited field of use, exclusive license to practice the inventions embodied in the patent application referred to below to Inviragen, LLC, having a place of business in Fort Collins, Colorado. The patent rights in these inventions have been assigned to the government of the United States of America. SUPPLEMENTARY INFORMATION: In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i), CDC is providing public notice of its intention to grant an exclusive license. CDC will accept written comments concerning this notice for 30 days after publication of this notice. Applications for a license filed in response to this notice will be treated as objections to the grant of the contemplated license. Comments and objections submitted in response to this notice will not be made available for public inspection, and, to the extent permitted by law, will not be released under the Freedom of Information Act, 5 U.S.C. 552. A signed Confidential Disclosure Agreement (available under Forms @ https://www.cdc.gov/tto) will be required to receive a copy of any pending patent application. The patent application(s) to be licensed are: PCT/US01/05142 entitled ‘‘Chimeric Dengue Viruses as Candidate Vaccines for Humans,’’ filed February 16, 2001. Status: Received notice of allowance. Issue Date: N/A The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. Technology: This technology provides a new pathway for a dengue virus vaccine. ADDRESSES: Requests for a copy of this patent application, inquiries, comments, and other materials relating to the E:\FR\FM\21MRN1.SGM 21MRN1

Agencies

[Federal Register Volume 71, Number 54 (Tuesday, March 21, 2006)]
[Notices]
[Page 14221]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-2653]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Center for Environmental Health/Agency for Toxic 
Substances and Disease Registry

    The Board of Scientific Counselors, Centers for Disease Control and 
Prevention (CDC), National Center for Environmental Health/Agency for 
Toxic Substances and Disease Registry (NCEH/ATSDR): Meeting.
    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), CDC and NCEH/ATSDR announce the 
following committee meeting:
    Name: Board of Scientific Counselors (BSC), NCEH/ATSDR.
    Times and Dates: 8 a.m. -4:45 p.m., May 4, 2006. 8 a.m.-12:15 p.m., 
May 5, 2006.
    Place: 1825 Century Boulevard, Atlanta, Georgia 30345.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 75 people.
    Purpose: The Secretary, Department of Health and Human Services 
(HHS) and by delegation, the Director, CDC, and Administrator, NCEH/
ATSDR, are authorized under section 301 (42 U.S.C. 241) and section 311 
(42 U.S.C. 243) of the Public Health Service Act, as amended, to: (1) 
Conduct, encourage, cooperate with, and assist other appropriate public 
authorities, scientific institutions, and scientists in the conduct of 
research, investigations, experiments, demonstrations, and studies 
relating to the causes, diagnosis, treatment, control, and prevention 
of physical and mental diseases and other impairments; (2) assist 
states and their political subdivisions in the prevention of infectious 
diseases and other preventable conditions and in the promotion of 
health and well being; and (3) train state and local personnel in 
health work. The BSC, NCEH/ATSDR provides advice and guidance to the 
Secretary, HHS; the Director, CDC, and Administrator, ATSDR; and the 
Director, NCEH/ATSDR, regarding program goals, objectives, strategies, 
and priorities in fulfillment of the agency's mission to protect and 
promote people's health. The board provides advice and guidance that 
will assist NCEH/ATSDR in ensuring scientific quality, timeliness, 
utility, and dissemination of results. The board also provides guidance 
to help NCEH/ATSDR work more efficiently and effectively with its 
various constituents and to fulfill its mission in protecting America's 
health.
    Matters To Be Discussed: Items will include but are not limited to 
a discussion of Fiscal Years 2006 and 2007 budget implications; an 
update on the peer review of the Air Pollution and Respiratory Health 
Branch and the Division of Toxicology and Environmental Medicine; a 
discussion of the Program Peer Review Subcommittee process; updates on 
the Community and Tribal Subcommittee, the Health Department 
Subcommittee and the Delisting Workgroup; a discussion on the 
implications of the Office of Management and Budget Data Quality 
Guidelines and proposed bulletin on risk assessments; a discussion on 
the environmental health aspects of pandemic flu planning, the 
environmental health implications; discussion on future goals, 
directions, and new priorities; and an introduction of the Goals' 
Managers.
    Agenda items are tentative and subject to change.

FOR FURTHER INFORMATION CONTACT: Sandra Malcom, Committee Management 
Specialist, NCEH/ATSDR, 1600 Clifton Road, Mail Stop E-28, Atlanta, 
Georgia 30303; telephone (404) 498-0003, fax (404) 498-0622; E-mail: 
smalcom@cdc.gov. The deadline for notification of attendance is April 
24, 2006.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both CDC and NCEH/ATSDR.

    Dated: March 14, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 06-2653 Filed 3-20-06; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.